Get the Stockscreener App
310.01
0.31%
-0.95
After Hours:
310.01
Bio Rad Laboratories Inc stock is traded at $310.01, with a volume of 179.34K.
It is down -0.31% in the last 24 hours and up +1.48% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$310.96
Open:
$308.65
24h Volume:
179.34K
Relative Volume:
0.77
Market Cap:
$6.82B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-11.34
EPS:
-27.33
Net Cash Flow:
$223.75M
1W Performance:
-2.96%
1M Performance:
+1.48%
6M Performance:
+29.07%
1Y Performance:
-17.17%
1-Day Range:
$303.44
$312.87
1-Week Range:
$298.22
$328.96
52-Week Range:
$211.43
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
310.01 | 8.39B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
124.54 | 218.75B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.90 | 146.52B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
357.67 | 138.67B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.40 | 115.97B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.84 | 49.40B | 5.88B | 1.34B | 577.90M | 2.3455 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-03-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-07-23 | Initiated | UBS | Buy |
| Jun-16-23 | Initiated | Wells Fargo | Overweight |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jan-28-22 | Reiterated | Citigroup | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-17-18 | Initiated | Goldman | Buy |
| Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-16-18 | Downgrade | CL King | Buy → Neutral |
| Jul-13-17 | Initiated | Wells Fargo | Outperform |
| Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Hold |
| Oct-13-16 | Initiated | CL King | Buy |
| May-06-15 | Reiterated | Jefferies | Buy |
| Dec-18-09 | Initiated | Maxim Group | Buy |
| Nov-06-09 | Initiated | Jefferies & Co | Buy |
| Jul-17-09 | Initiated | Soleil | Buy |
| Sep-26-07 | Initiated | Banc of America Sec | Buy |
| Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
Tech Rally: How rising interest rates impact Bio Rad Laboratories Inc. stockCPI Data & High Conviction Investment Ideas - fcp.pa.gov.br
Can Bio Rad Laboratories Inc. stock sustain revenue growth2025 EndofYear Setup & Safe Entry Zone Tips - newser.com
How to manage a losing position in Bio Rad Laboratories Inc.July 2025 Reactions & Accurate Buy Signal Alerts - newser.com
Published on: 2025-11-05 20:10:58 - fcp.pa.gov.br
United States Blood Testing Market 2025: Size Share, Trends, - openPR.com
Can trapped investors hope for a rebound in Bio Rad Laboratories Inc.July 2025 PostEarnings & AI Driven Stock Price Forecasts - newser.com
Will Bio Rad Laboratories Inc. Class stock outperform value peersPortfolio Growth Summary & Fast Gaining Stock Reports - newser.com
How Bio Rad Laboratories Inc. (BUW) stock stacks up against competitorsWeekly Trade Recap & Low Risk Profit Maximizing Plans - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock beat Nasdaq index returnsLong Setup & Risk Adjusted Swing Trade Ideas - newser.com
What market sentiment indicators show for Bio Rad Laboratories Inc. (BUWA) stockBull Run & Weekly Top Gainers Trade List - newser.com
What recovery options are there for Bio Rad Laboratories Inc.Treasury Yields & AI Powered Market Entry Ideas - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock attract long term capital inflows2025 Market Overview & Precise Swing Trade Entry Alerts - newser.com
Why global investors buy Bio Rad Laboratories Inc. (BUWA) stockJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com
Understanding Bio Rad Laboratories Inc.’s price movement2025 Key Lessons & Safe Investment Capital Preservation Plans - newser.com
How Bio Rad Laboratories Inc. (BUW) stock reacts to weak economyEarnings Overview Summary & Community Verified Swing Trade Signals - newser.com
How to build a dashboard for Bio Rad Laboratories Inc. stockTrade Volume Summary & Growth Focused Stock Reports - newser.com
Bio Rad Laboratories Inc. stock trend forecast2025 Major Catalysts & Weekly Sector Rotation Insights - newser.com
Is Bio Rad Laboratories Inc. stock supported by strong cash flowsWatch List & High Accuracy Swing Entry Alerts - newser.com
United States Next Generation Sequencing (NGS) Market Rapid - openPR.com
Is Bio Rad Laboratories Inc. stock a bargain at current levelsDip Buying & Free Weekly Watchlist of Top Performers - newser.com
Will Bio Rad Laboratories Inc. Class stock sustain bullish trend into 2025Treasury Yields & AI Powered Trade Plan Recommendations - newser.com
What macro factors could drive Bio Rad Laboratories Inc. Class stock higherJuly 2025 Review & Weekly Watchlist for Consistent Profits - newser.com
Is Bio Rad Laboratories Inc. (BUWA) stock a top hedge fund pickJuly 2025 Opening Moves & Stock Market Timing Techniques - newser.com
How geopolitical risks impact Bio Rad Laboratories Inc. (BUWA) stockInsider Selling & Precise Buy Zone Tips - newser.com
What to expect from Bio Rad Laboratories Inc. in the next 30 daysEarnings Risk Summary & Real-Time Volume Spike Alerts - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock deliver compounding returnsJuly 2025 Recap & Free Daily Entry Point Trade Alerts - newser.com
Why Bio Rad Laboratories Inc. (BUW) stock is upgraded to buy2025 Market WrapUp & Safe Entry Point Identification - newser.com
Plato Investment Management Ltd Increases Stock Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Exit strategy if you’re trapped in Bio Rad Laboratories Inc.2025 Price Targets & Weekly High Momentum Picks - newser.com
How Bio Rad Laboratories Inc. Class B stock responds to bond market - newser.com
How strong is Bio Rad Laboratories Inc. stock balance sheetAnalyst Downgrade & Risk Controlled Daily Plans - newser.com
Is Bio Rad Laboratories Inc. forming a bottoming baseGDP Growth & Reliable Intraday Trade Plans - newser.com
Using R and stats models for Bio Rad Laboratories Inc. forecastingWeekly Investment Recap & Step-by-Step Swing Trade Plans - newser.com
Is Bio Rad Laboratories Inc. Class B stock a buy before new product rollout2025 Top Gainers & Community Verified Trade Signals - newser.com
Assetmark Inc. Buys 12,023 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
HbA1c Testing Market Research Report 2025-2033, Profiles of - GlobeNewswire
HbA1c Testing Market Research Report 2025-2033, Profiles of Key PlayersDanaher, F. Hoffmann-La Roche, Siemens, Abbott, Bio-Rad Laboratories, ARKRAY, Trinity Biotech, EKF Diagnostics - Yahoo Finance
Will Bio Rad Laboratories Inc. Class B stock deliver stable dividends2025 Price Action Summary & Step-by-Step Swing Trade Plans - newser.com
Is Bio Rad Laboratories Inc. meeting your algorithmic filter criteria2025 Retail Activity & Accurate Buy Signal Notifications - newser.com
What valuation ratios show for Bio Rad Laboratories Inc. Class stockMarket Growth Report & Stepwise Trade Signal Implementation - newser.com
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):